Identifying aggressive forms of endometrioid-type endometrial cancer: New insights into molecular subtyping

Yuexin Liu, Russell R. Broaddus, Wei Zhang

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Clinical heterogeneity represents a great challenge for cancer therapeutics. Molecular classification of patients into different subtypes based on genetic or epigenetic characteristics has the potential to revolutionize the clinical care and mechanistic understanding of a wide spectrum of cancers, including endometrial carcinoma, the most common gynecological cancer affecting women.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalExpert review of anticancer therapy
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2014

Keywords

  • CTNNB1 mutation
  • cancer therapeutics
  • endometrial carcinoma
  • molecular subtyping
  • wnt signaling pathway

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

MD Anderson CCSG core facilities

  • Bioinformatics Shared Resource

Fingerprint

Dive into the research topics of 'Identifying aggressive forms of endometrioid-type endometrial cancer: New insights into molecular subtyping'. Together they form a unique fingerprint.

Cite this